US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HARBOR HEALTH CARE ETF

33.38

-0.0031-0.01%

Post-market: 33.430.0518+0.16%19:30 EDT

Volume:4K

Turnover:131.43K

Market Cap:42.56M

PE:- -

High:33.89

Open:33.89

Low:33.33

Close:33.38

52wk High:35.61

52wk Low:27.50

Shares:1.28M

Float Shares:1.28M

Volume Ratio:1.00

T/O Rate:0.31%

Dividend:0.08

Dividend Rate:0.23%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Atai Beckley Holds Shareholder Meeting, Quorum Met with 65.6% Shares Represented

Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program with Gilead

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors

Assembly Bio Highlights Phase 2 Starts for ABI-6250, GS-1179 in Pipeline Update

Structure weakness ‘disconnected’ from underlying data, says Jefferies

Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for Hsv Helicase-Primase Inhibitor Program

THOMSON REUTERS

Assembly Biosciences - Assembly Bio Eligible for up to $280 Mln in Milestones and Royalties Outside U.S.

THOMSON REUTERS

Assembly Biosciences - Gs-1179 Expected to Advance into Phase 2 Trial for Genital Herpes by End of 2026

THOMSON REUTERS

Assembly Biosciences - Gilead Retains Sole Right for Clinical Development and Commercialization of Hsv Hpi Program

THOMSON REUTERS

Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback

Gilead Sciences Inc Stock (GILD) Moved Down by 3.26% on Sep 8: Drivers Behind the Movement

Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines

THOMSON REUTERS

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

Mirum Pharmaceuticals Names Rob Myers Chief Medical Officer Effective Sept. 21, 2026

AlzeCure Pharma to Present at Aktiedagen Event in Stockholm

Gilead Sciences (GILD) Receives a Buy from Bernstein

Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids

ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review

Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/MEDI/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MEDI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDI\",,,,,undefined,":{"symbol":"MEDI","market":"US","secType":"STK","nameCN":"HARBOR HEALTH CARE ETF","latestPrice":33.3782,"timestamp":1789156800000,"preClose":33.3813,"halted":0,"volume":3922,"hourTrading":{"tag":"盘后","latestPrice":33.43,"preClose":33.3782,"latestTime":"19:30 EDT","volume":9,"amount":300.4038,"timestamp":1789169406755,"change":0.0518,"changeRate":0.001552,"amplitude":0},"delay":0,"changeRate":-0.00009286636530043567,"floatShares":1275000,"shares":1275000,"eps":0,"marketStatus":"Market Closed","change":-0.0031,"latestTime":"09-11 16:00:00 EDT","open":33.89,"high":33.89,"low":33.33,"amount":131427.51426000003,"amplitude":0.016776,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":33.3813,"sharesOutstanding":925000,"nav":33.383047,"aum":42563384.99,"dividendRate":0.002262,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.43,"preClose":33.3782,"latestTime":"19:30 EDT","volume":9,"amount":300.4038,"timestamp":1789169406755,"change":0.0518,"changeRate":0.001552,"amplitude":0},"volumeRatio":0.9983200452531705},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDI\",,,,,undefined,":{"symbol":"MEDI","floatShares":1275000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9983200452531705,"shares":1275000,"dividePrice":0.0755,"high":33.89,"amplitude":0.016776,"preClose":33.3813,"low":33.33,"week52Low":27.5,"pbRate":"--","week52High":35.605,"institutionHeld":0,"latestPrice":33.3782,"eps":0,"divideRate":0.002262,"volume":3922,"delay":0,"ttmEps":0,"open":33.89,"prevYearClose":31.45,"prevWeekClose":34.3659,"prevMonthClose":34.24,"prevQuarterClose":33.84,"fiveDayClose":34.669,"twentyDayClose":34.06,"sixtyDayClose":31.1652},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDI\",params:#limit:5,,,undefined,":[{"date":"2025-12-19","symbol":"MEDI","amount":0.07515,"announcedDate":"2025-12-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-19","defaultRemindTime":1766154600000,"name":"HARBOR HEALTH CARE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-19","currency":"USD","dateTimestamp":1766120400000,"payDate":"2025-12-24"},{"date":"2024-12-20","symbol":"MEDI","amount":0.13455,"announcedDate":"2024-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"HARBOR HEALTH CARE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-26"},{"date":"2023-12-21","symbol":"MEDI","amount":0.4613,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-22","defaultRemindTime":1703169000000,"name":"HARBOR HEALTH CARE ETF","recordDate":"2023-12-27","payableDate":"2023-12-22","currency":"USD","dateTimestamp":1703134800000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDI\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-21","recordDate":"2023-12-22","paymentDate":"2023-12-27","value":0.4613,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-26","value":0.13455,"currency":"USD"},{"executeDate":"2025-12-19","recordDate":"2025-12-19","paymentDate":"2025-12-24","value":0.07515,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDI\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666370615","title":"Atai Beckley Holds Shareholder Meeting, Quorum Met with 65.6% Shares Represented","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370615","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370615?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:10","pubTimestamp":1788901814,"startTime":"0","endTime":"0","summary":"Atai Beckley holds shareholder meeting, quorum met with 65.6% shares representedAtai Beckley held a virtual special shareholder meeting on Sept. 8, 2026 to vote on a merger agreement with Eli Lilly.Sh","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL1JLSHz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2213496289.HKD","FHLC","LU1548497426.USD","LU2237443622.USD","BK4516","LU0210536198.USD","LU1623119135.USD","LU0096364046.USD","SGXZ31699556.SGD","XLV","LU0158827781.USD","LU0820561818.USD","ILDR","IE00B1BXHZ80.USD","LU0823434583.USD","IE00BK4W5L77.USD","BK4539","IE0005OL40V9.USD","LU0943347566.SGD","IXJ","BK4533","GDOC","LU2756315318.SGD","LU2357305700.SGD","LU0316494557.USD","SG9999001176.USD","IE00BJJMRZ35.SGD","LU1868836757.USD","JDOC","LU0106261372.USD","LU2237443895.HKD","LU0354030438.USD","LU2324357040.USD","LU2471134796.USD","LU2063271972.USD","IE00BFTCPJ56.SGD","TMED","LU2552382215.SGD","LU1551013342.USD","LU0385154629.USD","LU0345770308.USD","LU1127390331.HKD","LU0061475181.USD","LU1323610961.USD","LU0203202063.USD","LU2471134879.HKD","LU0114720955.EUR","LU0889565916.HKD","LU1093756168.USD","LU1712237335.SGD","LU2111349929.HKD","IE0004445015.USD","SG9999014906.USD","IE00BJJMRY28.SGD","LU2108987350.USD","LU2265009873.SGD","LU2491050071.SGD","SG9999013999.USD","SGXZ99366536.SGD","CANC","IE00BFSS8Q28.SGD","LU0689472784.USD","LU1720051017.SGD","LU2168564065.EUR","LU2237443382.USD","SG9999014898.SGD","LU2750360997.AUD","LU2023251221.USD","IE00BKPKM429.USD","LU0787776722.HKD","LU1064131342.USD","LU0203201768.USD","LU2087625088.SGD","SG9999017495.SGD","RXL","LU2089284900.SGD","LU0786609619.USD","BK4581","LU0174119429.USD","LU2417539215.USD","LU0289739699.SGD","BK4585","LU2361044865.SGD","LU0882574139.USD","IE00B4JS1V06.HKD","VHT","LU1814569148.SGD","PJP","LU2211815571.USD","LU0820561909.HKD","LU2023250504.SGD","LU2468319806.SGD","LU2491050154.USD","BK4588","LU0471298777.SGD","LU0432979614.USD","LU2746668461.USD","LU0256863811.USD","LU0122379950.USD","LU0266013472.USD","SG9999018857.SGD","LLII","LU0109391861.USD","LU0006306889.USD","LU1868836914.USD","LU2491049909.HKD","LU2471134952.CNY","LU0353189763.USD","LU1551013425.SGD","LU2271345857.HKD","LU1868837136.USD","SG9999015952.SGD","LU0354030511.USD","LU1868837300.USD","SGXZ51526630.SGD","LU0882574055.USD","ATAI","LU2461242641.AUD","LU2168563687.JPY","BK4534","LU2361045086.USD","LU0198837287.USD","LU2462591350.SGD","LU1061106388.HKD","LU1989771016.USD","SG9999014880.SGD","SG9999018865.SGD","IE00BK4W5M84.HKD","LU1023059063.AUD","LU1917777945.USD","LU2471134523.USD","IE00B775H168.HKD","LU1291159041.SGD","LU2264538146.SGD","LU0353189680.USD","LU0158827948.USD","LU1280957306.USD","LU2237443549.SGD","LU0094547139.USD","MHIP","LU0708995401.HKD","LLYZ","IE0004445239.USD","LU0323591593.USD","LU0672654240.SGD","LU1145028129.USD","THNR","LU0225283273.USD","FTXH","IE0002141913.USD","LU2750360641.GBP","LU1069344957.HKD","LU2756315664.SGD","LU1868836591.USD","CURE","BK4007","LU0320765992.SGD","LU0133085943.USD","LU0234572021.USD","LU0256863902.USD","LU0471298694.HKD","LU2112291526.USD","SG9999015986.USD","WDNA","LU0417517546.SGD","IHE","GB00BDT5M118.USD","LU2106854487.HKD","ELIS","IYH","LU0097036916.USD","SG9999001176.SGD","LU0820562030.AUD","LU0640476718.USD","LU2462157665.USD","LU2360106947.USD","LU1267930730.SGD","LU0058720904.USD","LU2361044949.HKD","LU1983299246.USD","LU2089283258.USD","MEDI","HRTS","LU2028103732.USD","IE0009355771.USD","LU2896262040.SGD","LU2089984988.USD","LU2237443465.HKD","LU0823434740.USD","LU2168564495.EUR","SGXZ57979304.SGD","IE00BJJMRX11.SGD","IE00BWXC8680.SGD","LU1232071149.USD","IE00BFSS7M15.SGD","LU0964807845.USD","IE00B1XK9C88.USD","LU1979441026.SGD","LU0823416689.USD","IE00BJT1NW94.SGD","LU2552382132.HKD","LU0238689110.USD","SG9999014914.USD","AGNG","SG9999015945.SGD","TRUH","LU2602419157.SGD","LU0683600562.USD","LU0345770993.USD","LU2237438978.USD","IE00B4R5TH58.HKD","LU0320765059.SGD","LU2168564149.EUR","SGXZ81514606.USD","LU2023250330.USD","SG9999015978.USD","LLY","LU0079474960.USD","LU1804176565.USD","LU2237443978.SGD","ELIL","LU1366192091.USD","LU1035775433.USD","IE00B2B36J28.USD","BK4599","LU1691799644.USD","LU2168564222.USD","LU1093756325.SGD","OZEM","LU1974910355.USD","LU2236285917.USD","IE00B7KXQ091.USD","IE00BN29S564.USD","LU1629891620.HKD","LU0456855351.SGD","LU1720051108.HKD","LU2456880835.USD","IE00BJLML261.HKD","LU0109394709.USD","IE0001KFT4U8.USD","LU2552382058.USD","LU0466842654.USD","LU1057294990.SGD","PPH","IE00BKDWB100.SGD","MEDX","LU2746668974.SGD","LU1988902786.USD","LLYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377026","title":"Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program with Gilead","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377026","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377026?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:49","pubTimestamp":1788900540,"startTime":"0","endTime":"0","summary":"Assembly Biosciences said it exercised a profit-sharing option for the development of a herpes treatment under its collaboration agreement with Gilead Sciences.The biotechnology company said it will s","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","BBH","BIB","LU1674673691.USD","LU2468319806.SGD","LU0823416689.USD","ASMB","BK4568","BK4588","IBBQ","IE00B3T34201.USD","LU0320765992.SGD","LU1934455277.USD","LU2087621335.USD","LU1061106388.HKD","LU1037948897.HKD","LU2357627491.SGD","BK4532","LU0861579265.USD","BK4139","BK4583","LU0234570918.USD","SG9999015952.SGD","IE0002270589.USD","BK4566","SG9999015978.USD","BK4550","LU0109394709.USD","LU1066053197.SGD","LU1037948541.HKD","LU0965508806.USD","LU2324357040.USD","LU0122379950.USD","IBB","LU1585245621.USD","LU0965509101.SGD","LU0859254822.USD","LU0889565916.HKD","LU1057294990.SGD","LU1839511570.USD","TMED","SG9999015945.SGD","LU1066051498.USD","GILD","LU1674673428.USD","IE00BSNM7G36.USD","BMED","MEDI","IE00BKVL7J92.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666416377","title":"Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666416377","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666416377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:35","pubTimestamp":1788899700,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slid 2.88% to $146.64 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,673.52 and Dow Jones Industrial Average  falling 1.18% to 52,786.07.This was the stock's second consecutive day of losses.Gilead Sciences Inc. closed 6.77% below its 52-week high of $157.29, which the company reached on February 11th.The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 2.22% to $269.12, Pfizer Inc.  fell 2.32% to $27.79, and Abbott Laboratories  fell 2.59% to $105.52.Trading volume  remained 673,543 below its 50-day average volume of 6.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","BK4550","BK4583","IE00B7SZLL34.SGD","LU0058720904.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","LU1023059063.AUD","LU2089984988.USD","LU0965509010.AUD","LU0965509101.SGD","LU1430594728.SGD","IE00BSNM7G36.USD","BBH","LU2112291526.USD","LU1934455863.HKD","LU0965508806.USD","LU1061106388.HKD","BK4566","LU2468319806.SGD","SG9999015952.SGD","LU0882574055.USD","LU1674673691.USD","LU0861579265.USD","LU1037948541.HKD","LU2324357040.USD","LU1839511570.USD","LU0889565916.HKD","LU2087621335.USD","LU1066051498.USD","LU1778281490.HKD","BK4585","LU0114720955.EUR","MEDI","IE0002270589.USD","LU1934455194.USD","IE00B19Z3581.USD","TBXU","LU0823416689.USD","BK4532","IE00BKVL7J92.USD","LU1037948897.HKD","SG9999015945.SGD","LU0234570918.USD","GILD","IBBQ","LU0320765992.SGD","IE00B3T34201.USD","LU1934455277.USD","LU2357627491.SGD","LU1066053197.SGD","SG9999015986.USD","BK4139","BK4568","IBB","LU0122379950.USD","LU0289739699.SGD","LU0965509283.SGD","LU1674673428.USD","LU0109394709.USD","LU0859254822.USD","TMED","BK4588","IE00B19Z3B42.SGD","BK4578","BIB","LU1057294990.SGD","LU1571399168.USD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377856","title":"Assembly Bio Highlights Phase 2 Starts for ABI-6250, GS-1179 in Pipeline Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377856","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377856?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:08","pubTimestamp":1788898126,"startTime":"0","endTime":"0","summary":"Assembly Bio highlights Phase 2 starts for ABI-6250, GS-1179 in pipeline updateAssembly Biosciences outlined multiple Phase 2 starts across its portfolio in 2026 to early 2027, led by ABI-6250 in live","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL58BQBh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU1037948541.HKD","LU1037948897.HKD","BK4566","LU0861579265.USD","BK4583","LU1674673428.USD","IE00B3T34201.USD","LU0289739699.SGD","BK4585","BMED","GILD","LU0234570918.USD","LU1778281490.HKD","LU2468319806.SGD","SG9999015978.USD","BK4588","IE00BKVL7J92.USD","LU2324357040.USD","LU2357627491.SGD","IE0002270589.USD","LU1934455277.USD","TMED","LU0965508806.USD","LU1934455863.HKD","BK4568","LU0320765992.SGD","IE00BZ1G4Q59.USD","LU0965509283.SGD","LU2112291526.USD","SG9999015986.USD","IBB","LU0889565916.HKD","IBBQ","TBXU","LU1585245621.USD","LU1571399168.USD","LU1674673691.USD","IE00B7SZLL34.SGD","LU0109394709.USD","ASMB","IE00BSNM7G36.USD","LU0058720904.USD","BIB","LU1066053197.SGD","LU0965509101.SGD","MEDI","BBH","LU1023059063.AUD","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APXH","BME","IBRN","GNOM","SBIO","IBBQ","GPCR","IBBJ","IBB","RSPH","XPH","CURE","MEDI","SURI","GNMX","JDOC","BBH","FHLC","MDTX","MEDX","BIB","MNTL","SYNB","PBE","PJP","JHMH","LFSC","FBT","PSCH","PTH","HYLG","LLYX","GDOC","WDNA","NVIB","MRNY","PSIL","HRTS","PBPH","TBXU","PINK","FTXH","CANC","IEIH","GSKH","CNCR","FXH","AZNH","IDNA","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666937221","title":"Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for Hsv Helicase-Primase Inhibitor Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666937221","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666937221?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA4XVZNR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBB","IE00B19Z3B42.SGD","LU1674673428.USD","SG9999015945.SGD","ASMB","LU0859254822.USD","LU2089984988.USD","LU1674673691.USD","LU1430594728.SGD","BMED","SG9999015978.USD","SG9999015952.SGD","BK4566","BK4588","BK4550","TMED","LU0965509010.AUD","LU0889565916.HKD","IE00BKVL7J92.USD","LU0320765992.SGD","IE00B3T34201.USD","LU0122379950.USD","LU1061106388.HKD","LU1023059063.AUD","IE0002270589.USD","IBBQ","BK4578","LU0234570918.USD","BIB","BBH","LU0289739699.SGD","LU0965509283.SGD","LU1934455863.HKD","LU1778281490.HKD","SG9999015986.USD","LU1585245621.USD","LU2357627491.SGD","LU1037948541.HKD","MEDI","GILD","IE00B19Z3581.USD","TBXU","LU2468319806.SGD","LU1839511570.USD","LU0823416689.USD","LU1934455194.USD","LU0058720904.USD","LU1934455277.USD","IE00BZ1G4Q59.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666437220","title":"Assembly Biosciences - Assembly Bio Eligible for up to $280 Mln in Milestones and Royalties Outside U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2666437220","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666437220?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA4XVZNR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B3T34201.USD","LU1585245621.USD","TBXU","LU1934455863.HKD","LU1061106388.HKD","IE00BKVL7J92.USD","BK4583","LU0234570918.USD","LU1674673428.USD","LU1934455277.USD","IBB","LU1023059063.AUD","IE00B7SZLL34.SGD","LU0965509283.SGD","BK4568","GILD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU2324357040.USD","LU1037948897.HKD","LU1066051498.USD","LU0058720904.USD","LU1066053197.SGD","LU1571399168.USD","IE00BZ1G4Q59.USD","LU0965509101.SGD","LU1430594728.SGD","LU2089984988.USD","LU0882574055.USD","BK4550","TMED","LU2468319806.SGD","SG9999015978.USD","BK4139","BK4532","SG9999015952.SGD","LU2112291526.USD","BBH","BMED","BK4578","BK4588","LU1839511570.USD","BIB","LU1934455194.USD","ASMB","IBBQ","LU0889565916.HKD","LU0114720955.EUR","MEDI","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372203","title":"Assembly Biosciences - Gs-1179 Expected to Advance into Phase 2 Trial for Genital Herpes by End of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372203","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372203?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA4XVZNR:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDI","IE00BKVL7J92.USD","SG9999015978.USD","LU0320765992.SGD","LU1430594728.SGD","LU0859254822.USD","LU1674673428.USD","LU2468319806.SGD","BMED","GILD","IE00B19Z3B42.SGD","BK4585","IBBQ","LU1934455277.USD","LU1066051498.USD","LU1934455863.HKD","BK4568","IBB","LU0965508806.USD","BK4588","LU1057294990.SGD","LU2324357040.USD","IE0002270589.USD","LU1674673691.USD","LU2087621335.USD","LU0109394709.USD","BK4532","BBH","LU0289739699.SGD","LU1037948541.HKD","ASMB","BIB","LU2089984988.USD","LU1839511570.USD","BK4550","LU1571399168.USD","IE00B7SZLL34.SGD","LU0823416689.USD","LU0882574055.USD","LU0965509283.SGD","SG9999015986.USD","TMED","LU2112291526.USD","LU1934455194.USD","LU0234570918.USD","BK4139","TBXU","LU1037948897.HKD","IE00BSNM7G36.USD","LU0965509010.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666216372","title":"Assembly Biosciences - Gilead Retains Sole Right for Clinical Development and Commercialization of Hsv Hpi Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666216372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666216372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA4XVZNR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDI","LU0965509010.AUD","SG9999015986.USD","TBXU","BBH","BIB","LU1674673691.USD","LU2468319806.SGD","ASMB","BK4568","IBBQ","LU0114720955.EUR","LU0320765992.SGD","LU1934455277.USD","LU2112291526.USD","LU1037948897.HKD","BK4585","BK4532","LU1430594728.SGD","LU0861579265.USD","BK4139","BK4583","LU0234570918.USD","LU0882574055.USD","IE0002270589.USD","BK4566","SG9999015978.USD","BK4550","LU0109394709.USD","LU1066053197.SGD","LU2324357040.USD","LU0122379950.USD","IBB","LU1585245621.USD","LU1934455863.HKD","LU0859254822.USD","LU0889565916.HKD","LU1057294990.SGD","LU1839511570.USD","TMED","SG9999015945.SGD","GILD","LU1674673428.USD","IE00BSNM7G36.USD","LU0965509283.SGD","BMED","LU1934455194.USD","BK4578","IE00BKVL7J92.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374281","title":"Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374281","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374281?lang=en_us&edition=fundamental","pubTime":"2026-09-09 02:03","pubTimestamp":1788890602,"startTime":"0","endTime":"0","summary":"Cardiovascular disease treatments are potentially lucrative for the pharma industry.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/eli-lilly-stock-lly-falls-on-news-of-competitor-novartis-cholesterol-drug-setback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/eli-lilly-stock-lly-falls-on-news-of-competitor-novartis-cholesterol-drug-setback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WDNA","IE00BK4W5M84.HKD","LU2491050071.SGD","GB00BDT5M118.USD","LU2168564065.EUR","LU2237443895.HKD","IE0002141913.USD","LU2237443622.USD","LU2462157665.USD","LU0058720904.USD","LU2265009873.SGD","LU0203201768.USD","MHIP","LU1989771016.USD","LU0882574055.USD","LU0823434583.USD","LU1988902786.USD","LU0096364046.USD","SGXZ99366536.SGD","MEDX","SG9999015952.SGD","LU1691799644.USD","LU1804176565.USD","IE0004445015.USD","LLY","MEDI","LU0133085943.USD","LU2211815571.USD","LU0823434740.USD","BK4581","LU0210536198.USD","LU2237443978.SGD","IE00BN29S564.USD","SG9999015978.USD","LU0466842654.USD","LU1280957306.USD","SGXZ81514606.USD","IE00BFSS8Q28.SGD","XLV","LU1720051017.SGD","LU1629891620.HKD","LU2023250330.USD","LU2168564495.EUR","FTXH","LU0316494557.USD","LU2213496289.HKD","LU0417517546.SGD","LU0106261372.USD","LU0256863811.USD","LU0266013472.USD","LU2087625088.SGD","BK4516","LU0234572021.USD","LU2089283258.USD","LU2237438978.USD","LU2756315664.SGD","LU0174119429.USD","IE0004445239.USD","LU2028103732.USD","PJP","LU1974910355.USD","IE00BJLML261.HKD","LU0354030511.USD","LU0689472784.USD","LU0203202063.USD","LU2237443465.HKD","LU1548497426.USD","SG9999001176.SGD","IE00B4R5TH58.HKD","LU1868837136.USD","LU2746668974.SGD","HRTS","LU2552382215.SGD","LU0354030438.USD","LU1069344957.HKD","LU2106854487.HKD","LU2491050154.USD","LU2089284900.SGD","IE0001KFT4U8.USD","BK4007","ELIS","IE00BJJMRY28.SGD","OZEM","LU2168564222.USD","IE00BK4W5L77.USD","LU1868837300.USD","LU1868836591.USD","LU1917777945.USD","CURE","LU0353189763.USD","SG9999014880.SGD","LU2552382058.USD","IXJ","LU0889565916.HKD","LU2324357040.USD","LU2357305700.SGD","IE00B2B36J28.USD","LU2750360641.GBP","IE0005OL40V9.USD","LU2361044865.SGD","LU1093756168.USD","SG9999015945.SGD","IE00B7KXQ091.USD","LU0820561909.HKD","LU2417539215.USD","LU0353189680.USD","LU2063271972.USD","LU2361044949.HKD","LU2750360997.AUD","LU1064131342.USD","LU2491049909.HKD","RXL","THNR","AGNG","LU0820561818.USD","LU0158827948.USD","CANC","LU0256863902.USD","LU1712237335.SGD","LU2360106947.USD","IE00BFSS7M15.SGD","IE00BKPKM429.USD","LU0823416689.USD","LU0079474960.USD","SG9999014906.USD","LU0238689110.USD","IE0009355771.USD","LU2471134952.CNY","BK4585","LU2111349929.HKD","LU2237443549.SGD","LU0943347566.SGD","LU0006306889.USD","LU1057294990.SGD","LU0640476718.USD","LU0158827781.USD","LU0323591593.USD","LU2471134796.USD","LU2756315318.SGD","SG9999017495.SGD","SG9999013999.USD","IHE","LLYZ","LU2023251221.USD","LU0109394709.USD","LU2361045086.USD","SG9999018857.SGD","LU2552382132.HKD","LU2023250504.SGD","LU1145028129.USD","TRUH","IE00B775H168.HKD","LU0432979614.USD","LU2168564149.EUR","LU2468319806.SGD","LLII","LU2456880835.USD","SG9999001176.USD","LU2236285917.USD","FHLC","SG9999018865.SGD","LU1267930730.SGD","BK4588","LU2471134879.HKD","LU2112291526.USD","LU0345770993.USD","LU0320765059.SGD","LU0786609619.USD","LU1623119135.USD","LU0787776722.HKD","SGXZ51526630.SGD","LU1035775433.USD","LU1093756325.SGD","LU1979441026.SGD","LU1232071149.USD","IE00BKDWB100.SGD","LU0225283273.USD","LU0122379950.USD","LU0683600562.USD","LU0198837287.USD","LU2746668461.USD","JDOC","LU1366192091.USD","LU2108987350.USD","LU0109391861.USD","LU0471298777.SGD","LU2168563687.JPY","BK4534","IE00B1XK9C88.USD","LU0820562030.AUD","LU1868836914.USD","LU1720051108.HKD","LU1551013425.SGD","LU2237443382.USD","LU0882574139.USD","SG9999015986.USD","LU1551013342.USD","LU2602419157.SGD","LU0345770308.USD","LU1127390331.HKD","SGXZ31699556.SGD","IE00BJJMRX11.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU1061106388.HKD","ELIL","IE00B1BXHZ80.USD","LU0672654240.SGD","VHT","LU1291159041.SGD","LU1023059063.AUD","LU1983299246.USD","IE00B4JS1V06.HKD","LU2264538146.SGD","LU2462591350.SGD","LU0320765992.SGD","LU1323610961.USD","ILDR","LU0114720955.EUR","LU2089984988.USD","LU0094547139.USD","LU0456855351.SGD","LU1868836757.USD","SG9999014914.USD","PPH","IE00BFTCPJ56.SGD","BK4599","LU0061475181.USD","LU0471298694.HKD","LU1814569148.SGD","GDOC","IYH","LU2461242641.AUD","LU0708995401.HKD","IE00BWXC8680.SGD","TMED","LLYX","LU2896262040.SGD","LU0385154629.USD","SG9999014898.SGD","LU2271345857.HKD","SGXZ57979304.SGD","LU2471134523.USD","LU0097036916.USD","BK4533","LU0964807845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374571","title":"Gilead Sciences Inc Stock (GILD) Moved Down by 3.26% on Sep 8: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374571","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374571?lang=en_us&edition=fundamental","pubTime":"2026-09-09 01:15","pubTimestamp":1788887735,"startTime":"0","endTime":"0","summary":"• Gilead pulled back due to profit-taking following a sustained multi-month rally.\n• Strong second-quarter revenue was driven by flagship HIV and Trodelvy franchises.\n• Analysts maintain Buy ratings with an average price target of $157.79.","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262156548-market-movers-gild-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","SG9999015945.SGD","LU0289739699.SGD","LU1061106388.HKD","TBXU","MEDI","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU1934455277.USD","IE00B19Z3581.USD","LU0889565916.HKD","LU0965509283.SGD","LU0859254822.USD","LU1571399168.USD","LU1674673428.USD","LU2089984988.USD","LU0122379950.USD","LU2468319806.SGD","LU0965509010.AUD","BK4578","LU1057294990.SGD","LU1430594728.SGD","LU1066053197.SGD","GILD","LU1585245621.USD","BK4550","BIB","BK4532","BMED","LU1778281490.HKD","LU0234570918.USD","LU1066051498.USD","LU1023059063.AUD","LU0965508806.USD","BK4568","BK4588","LU1674673691.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","LU0882574055.USD","LU1037948541.HKD","IBBQ","LU0965509101.SGD","LU0058720904.USD","BBH","SG9999015986.USD","IBB","IE00B19Z3B42.SGD","LU0109394709.USD","IE0002270589.USD","LU0823416689.USD","BK4139","LU2357627491.SGD","LU0320765992.SGD","IE00BZ1G4Q59.USD","SG9999015978.USD","TMED","LU1037948897.HKD","LU1934455863.HKD","SG9999015952.SGD","BK4583","LU2324357040.USD","BK4566","LU1839511570.USD","LU0861579265.USD","LU1934455194.USD","BK4585","LU2112291526.USD","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666717963","title":"Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2666717963","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666717963?lang=en_us&edition=fundamental","pubTime":"2026-09-09 01:00","pubTimestamp":1788886800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA5WKCFL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBBQ","LU2112291526.USD","LU0289739699.SGD","LU1585245621.USD","LU2089984988.USD","LU1037948897.HKD","IE00B3T34201.USD","IE00B7SZLL34.SGD","LU1778281490.HKD","BIB","LU1934455194.USD","BMED","LU0965509283.SGD","LU0320765992.SGD","LU1057294990.SGD","BBH","BK4532","TBXU","LU1023059063.AUD","LU2087621335.USD","LU1674673428.USD","TMED","IBB","LU1934455863.HKD","LU1066053197.SGD","LU2468319806.SGD","BK4578","MEDI","IE0002270589.USD","LU0122379950.USD","LU1839511570.USD","LU2324357040.USD","LU2357627491.SGD","LU0965508806.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD","SG9999015986.USD","IE00BSNM7G36.USD","BK4566","BK4585","IE00BZ1G4Q59.USD","LU0859254822.USD","BK4583","LU0823416689.USD","LU0882574055.USD","LU0234570918.USD","BK4550","LU1066051498.USD","GILD","LU1674673691.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665637847","title":"Structure Therapeutics reports ACCG-2671, aleniglipron trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665637847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665637847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:36","pubTimestamp":1788871007,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates: ACCG-2671, an oral, non-peptide, small molecule...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HRTS","FHLC","BME","FTXH","PJP","BIB","TBXU","PSCH","GSKH","CANC","AZNH","IBB","GNOM","NVIB","IBBQ","WDNA","FXH","PBE","CNCR","PBPH","PTH","LENZ","APXH","SBIO","LLYX","BBH","IDNA","CURE","GPCR","PINK","SURI","LFSC","JHMH","MEDX","IBBJ","XPH","SYNB","PSIL","MRNY","FBT","MDTX","MEDI","MNTL","JDOC","IBRN","HYLG","GNMX","BBP","RSPH","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665237857","title":"Mirum Pharmaceuticals Names Rob Myers Chief Medical Officer Effective Sept. 21, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665237857","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665237857?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:31","pubTimestamp":1788870661,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals names Rob Myers chief medical officer effective Sept. 21, 2026Mirum named Rob Myers as chief medical officer, effective Sept. 21, 2026, to lead global medical and clinical develo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLbq3cV8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU0965509101.SGD","LU2468319806.SGD","BK4532","BK4568","LU0289739699.SGD","LU0859254822.USD","LU1934455194.USD","LU0889565916.HKD","LU1037948541.HKD","MIRM","LU0965508806.USD","TMED","LU1057294990.SGD","LU2089984988.USD","LU1674673428.USD","LU0114720955.EUR","BIB","LU1778281490.HKD","BK4588","LU2087621335.USD","BK4550","IE00BZ1G4Q59.USD","LU1674673691.USD","BK4566","LU0320765992.SGD","LU1934455277.USD","MEDI","LU1571399168.USD","LU1585245621.USD","IE00B3T34201.USD","IBB","BK4578","SG9999015978.USD","IBBQ","LU0965509010.AUD","BBH","TBXU","IE00BKVL7J92.USD","LU0882574055.USD","LU1839511570.USD","BMED","IE0002270589.USD","SG9999015986.USD","BK4583","GILD","BK4585","LU1066051498.USD","LU2357627491.SGD","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665323952","title":"AlzeCure Pharma to Present at Aktiedagen Event in Stockholm","url":"https://stock-news.laohu8.com/highlight/detail?id=2665323952","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665323952?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:03","pubTimestamp":1788854584,"startTime":"0","endTime":"0","summary":"AlzeCure Pharma to present at Aktiedagen event in StockholmAlzeCure will present at Aktiespararna’s Aktiedagen in Stockholm on Sept. 15.CEO Martin Jnsson is scheduled to speak at 16:25 CEST at Birger ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL83QQ0r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKDWB100.SGD","SGXZ99366536.SGD","ELIL","LU2237443465.HKD","LU1069344957.HKD","LU1988902786.USD","LU2471134952.CNY","LU2491050071.SGD","IE00BJJMRY28.SGD","IE00BKPKM429.USD","LU0061475181.USD","LU0964807845.USD","LU1974910355.USD","LU2491050154.USD","LU2491049909.HKD","FTXH","LU2746668974.SGD","LU2471134796.USD","BK4534","LU1093756168.USD","LU0471298694.HKD","LU2236285917.USD","LU0109391861.USD","SGXZ51526630.SGD","LU2168564222.USD","IE00B4JS1V06.HKD","LU0354030438.USD","LU1127390331.HKD","LU2357305700.SGD","SG9999015945.SGD","LU1057294990.SGD","LU0820561818.USD","IE00B2B36J28.USD","LU0133085943.USD","LU2089284900.SGD","LU2756315664.SGD","IE00BFSS7M15.SGD","LU2237443382.USD","LU0058720904.USD","LU2089984988.USD","LU0787776722.HKD","LU0006306889.USD","IE0002141913.USD","LU0345770993.USD","LU0106261372.USD","LU0882574055.USD","LU2023250504.SGD","LU0708995401.HKD","LU2471134879.HKD","LU2168564065.EUR","TMED","BK4516","LU2106854487.HKD","IHE","IE0001KFT4U8.USD","IE0005OL40V9.USD","LU0096364046.USD","LU1814569148.SGD","LU1917777945.USD","IE00BJJMRX11.SGD","LU2265009873.SGD","IE0004445239.USD","IE00BN29S564.USD","IE00B775H168.HKD","LU1983299246.USD","LU0158827948.USD","LU0417517546.SGD","IE00BWXC8680.SGD","MEDI","LU2461242641.AUD","LU2462157665.USD","LU2756315318.SGD","LU2063271972.USD","LU1868837136.USD","GB00BDT5M118.USD","HRTS","LU1629891620.HKD","LU0882574139.USD","CURE","AGNG","LU1267930730.SGD","JDOC","LU2168564495.EUR","SG9999018857.SGD","LU0079474960.USD","LU2896262040.SGD","LU2361044865.SGD","LU2237443895.HKD","LU0320765059.SGD","LU2456880835.USD","LU0354030511.USD","LU0266013472.USD","BK4588","IE00B1BXHZ80.USD","LU0097036916.USD","LU2552382058.USD","LU0353189680.USD","TRUH","LU0786609619.USD","SG9999001176.USD","LU1868836591.USD","LU0471298777.SGD","SG9999014914.USD","IE0009355771.USD","LU0174119429.USD","LLYZ","LU2264538146.SGD","LU0345770308.USD","IE00BJJMRZ35.SGD","LU0316494557.USD","LU2361044949.HKD","IE00B4R5TH58.HKD","LU0683600562.USD","LU2211815571.USD","WDNA","RXL","LU0466842654.USD","PJP","LU0823434740.USD","LU0210536198.USD","LU1720051017.SGD","LU2213496289.HKD","LLY","SG9999014880.SGD","LU1548497426.USD","LU0456855351.SGD","LU0203201768.USD","LU1989771016.USD","IE00B1XK9C88.USD","LU2471134523.USD","SG9999015978.USD","BK4581","LU1720051108.HKD","MHIP","LU1232071149.USD","LU1291159041.SGD","LU1551013342.USD","IE00BJT1NW94.SGD","LU0203202063.USD","LU0094547139.USD","LU2108987350.USD","SGXZ81514606.USD","LU0640476718.USD","LU1979441026.SGD","LU0432979614.USD","LU0820561909.HKD","BK4585","LU0323591593.USD","LU2028103732.USD","VHT","LU0198837287.USD","LU2087625088.SGD","SG9999015952.SGD","LU1093756325.SGD","SG9999018865.SGD","LU2111349929.HKD","IE00B7KXQ091.USD","IE00BJLML261.HKD","LLYX","LU0109394709.USD","LU0158827781.USD","LU2089283258.USD","FHLC","LU1061106388.HKD","LU0353189763.USD","MEDX","OZEM","SGXZ57979304.SGD","ILDR","LU2237443549.SGD","LU1064131342.USD","LU0823416689.USD","LU1868836757.USD","LU2462591350.SGD","IE00BK4W5L77.USD","IXJ","LU2023250330.USD","SG9999001176.SGD","LU2271345857.HKD","LU0238689110.USD","LU1868836914.USD","LU2112291526.USD","IE00BFSS8Q28.SGD","LU1023059063.AUD","CANC","LU2237443978.SGD","LU0689472784.USD","LU2750360997.AUD","LU1323610961.USD","IE0004445015.USD","LU1623119135.USD","LU1868837300.USD","LU0823434583.USD","LU0943347566.SGD","SG9999013999.USD","LU2361045086.USD","LU2417539215.USD","LU0114720955.EUR","BK4007","LU0122379950.USD","LU0320765992.SGD","LU0672654240.SGD","BK4533","LU2168563687.JPY","LU2468319806.SGD","PPH","LU2552382132.HKD","LU1145028129.USD","LU2168564149.EUR","LU2237438978.USD","SGXZ31699556.SGD","LU1280957306.USD","LU2746668461.USD","LU0234572021.USD","IYH","LLII","IE00BFTCPJ56.SGD","LU0256863811.USD","LU2552382215.SGD","LU2750360641.GBP","SG9999014906.USD","LU2324357040.USD","LU0225283273.USD","SG9999014898.SGD","LU0889565916.HKD","GDOC","LU1366192091.USD","LU1804176565.USD","LU1035775433.USD","THNR","LU0289739699.SGD","LU1551013425.SGD","ELIS","LU2360106947.USD","BK4599","LU1691799644.USD","LU0256863902.USD","LU0385154629.USD","LU1712237335.SGD","SG9999015986.USD","LU2602419157.SGD","LU0820562030.AUD","SG9999017495.SGD","LU2023251221.USD","IE00BK4W5M84.HKD","XLV","LU2237443622.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665317041","title":"Gilead Sciences (GILD) Receives a Buy from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2665317041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665317041?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:25","pubTimestamp":1788798346,"startTime":"0","endTime":"0","summary":"Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences today and set a price target of $160.00. Breen covers the Healthcare se...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-receives-a-buy-from-bernstein-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-receives-a-buy-from-bernstein-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1571399168.USD","GILD","LU1778281490.HKD","LU1934455194.USD","TMED","SG9999015945.SGD","SG9999015952.SGD","BK4550","IE00B7SZLL34.SGD","LU1585245621.USD","BK4566","BK4585","LU0234570918.USD","XBI","IE00B19Z3B42.SGD","SG9999015978.USD","IE00BSNM7G36.USD","LU0965508806.USD","BBH","IE00BZ1G4Q59.USD","IE00B3T34201.USD","BMED","LU2324357040.USD","LU0882574055.USD","LU2089984988.USD","LU1839511570.USD","LU1934455277.USD","IBB","LU0114720955.EUR","BK4588","IBBQ","BK4581","LU1674673428.USD","MEDI","TBXU","XLV","LU0122379950.USD","LU1066051498.USD","LU1934455863.HKD","LU0823416689.USD","BIB","BK4578","LU1037948541.HKD","LU2112291526.USD","BK4139","IE0002270589.USD","IE00BKVL7J92.USD","LU0289739699.SGD","LABU","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185411766","title":"Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids","url":"https://stock-news.laohu8.com/highlight/detail?id=1185411766","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185411766?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:20","pubTimestamp":1788783624,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO.US) announced on Monday that in a late-stage clinical trial, its blockbuster weight-loss drug Wegovy's active ingredient, semaglutide, helped 40.4% of children aged 6 to under 12...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PINK","IYH","NVOX","THNR","BGIA","NBDS","FHLC","MEDI","RSPH","TRUH","FXH","NVOC","XLVI","NVOH","PJP","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665023390","title":"ASB Ventures-Backed Boundary Zhikong’s Navista eVTOL Navigation System Enters CAAC Airworthiness Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2665023390","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665023390?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:35","pubTimestamp":1788770131,"startTime":"0","endTime":"0","summary":"ASB Ventures-backed Boundary Zhikong’s Navista eVTOL navigation system enters CAAC airworthiness reviewShenzhen ASB Ventures portfolio company Boundary Intelligent Control secured CAAC acceptance of a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL7rkwzT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","LU2750360997.AUD","BK4599","LLII","LU1868837136.USD","LU0471298777.SGD","LU2264538146.SGD","IE00B4R5TH58.HKD","SGXZ81514606.USD","LU0882574055.USD","LU2108987350.USD","LU2552382215.SGD","IXJ","LU0106261372.USD","LU0234572021.USD","BK4534","LU2896262040.SGD","LU1623119135.USD","LU2357305700.SGD","THNR","LU2491050071.SGD","LU2468319806.SGD","LU2237438978.USD","LU2360106947.USD","LU2089283258.USD","LU2271345857.HKD","LU2237443895.HKD","LU2089984988.USD","SGXZ57979304.SGD","LU2491049909.HKD","LU1267930730.SGD","IE00B4JS1V06.HKD","SG9999015945.SGD","LU1093756325.SGD","LU2023250504.SGD","JDOC","IE00BJJMRZ35.SGD","ELIS","LU2168564065.EUR","PPH","IE00BK4W5L77.USD","IE0004445239.USD","LU1868836757.USD","LU2168564222.USD","CURE","LU1551013342.USD","LU2602419157.SGD","LU0353189763.USD","LU0210536198.USD","LU1868836591.USD","LU1127390331.HKD","IE0002141913.USD","BK4211","LU1323610961.USD","SG9999015978.USD","LU0289739699.SGD","FHLC","IE00BN29S564.USD","LU0820561818.USD","LU1548497426.USD","GB00BDT5M118.USD","LU2456880835.USD","LU1280957306.USD","LU2471134796.USD","LU2106854487.HKD","LU1868836914.USD","LU0345770993.USD","LU1979441026.SGD","IE00BFSS8Q28.SGD","LU1551013425.SGD","LU1989771016.USD","LU0323591593.USD","LU0061475181.USD","LU2361044949.HKD","SG9999018865.SGD","GDOC","LU1629891620.HKD","LU2112291526.USD","LU2471134952.CNY","LU2756315664.SGD","LU0708995401.HKD","SG9999014914.USD","LU0174119429.USD","LU0079474960.USD","LU0345770308.USD","LU0689472784.USD","LU1232071149.USD","IE00BJJMRX11.SGD","LU0417517546.SGD","LU0354030511.USD","LU1093756168.USD","LU0256863902.USD","LU2063271972.USD","LU1720051017.SGD","LU2237443382.USD","LU0238689110.USD","LU0889565916.HKD","LU2552382058.USD","LU0109394709.USD","LU2111349929.HKD","ASB","LU2461242641.AUD","LU1291159041.SGD","IE0005OL40V9.USD","LU1366192091.USD","MEDX","LU2028103732.USD","LU0320765059.SGD","LU2756315318.SGD","SG9999017495.SGD","LU0640476718.USD","MEDI","LU0096364046.USD","SG9999015986.USD","LU0058720904.USD","LU1720051108.HKD","LU2089284900.SGD","LU2023251221.USD","LLYZ","IE00BK4W5M84.HKD","IE00BKDWB100.SGD","LU0158827781.USD","LU0787776722.HKD","IE00BKPKM429.USD","LU0882574139.USD","IE00BJLML261.HKD","MHIP","IE0009355771.USD","LU0316494557.USD","LU0820562030.AUD","LU0256863811.USD","LU0266013472.USD","LU1974910355.USD","LU2237443549.SGD","LU1691799644.USD","LU0354030438.USD","IHE","LU2750360641.GBP","PJP","LU2023250330.USD","LU2471134879.HKD","LU0122379950.USD","HRTS","LU1814569148.SGD","BK4533","LU1023059063.AUD","LU2746668974.SGD","SG9999001176.SGD","BK4516","LU0203201768.USD","IE00B1BXHZ80.USD","IE0001KFT4U8.USD","VHT","LU1064131342.USD","IE00B775H168.HKD","LU1069344957.HKD","LU0823434740.USD","LU1988902786.USD","OZEM","ILDR","LU1983299246.USD","LU2462591350.SGD","LLY","LU0823416689.USD","SGXZ31699556.SGD","LU2471134523.USD","SG9999014906.USD","LU0353189680.USD","SGXZ99366536.SGD","LU0471298694.HKD","IE00BFTCPJ56.SGD","LU2211815571.USD","LU2237443978.SGD","LU2491050154.USD","LU2237443622.USD","AGNG","LU0198837287.USD","LU0225283273.USD","LU0823434583.USD","ELIL","IE00BWXC8680.SGD","LU2552382132.HKD","FTXH","LU0432979614.USD","LU1804176565.USD","LU0683600562.USD","CANC","SG9999014898.SGD","LU1917777945.USD","LU2417539215.USD","SG9999015952.SGD","WDNA","SGXZ51526630.SGD","SG9999018857.SGD","LU2168564149.EUR","LU2361045086.USD","LU0109391861.USD","SG9999014880.SGD","LU0006306889.USD","IE00B1XK9C88.USD","LU1712237335.SGD","IE00B2B36J28.USD","LU2265009873.SGD","LU0203202063.USD","LU0094547139.USD","LU1145028129.USD","LU0964807845.USD","LU0786609619.USD","LU1057294990.SGD","IE0004445015.USD","LU1868837300.USD","IE00BFSS7M15.SGD","LU2746668461.USD","IYH","SG9999013999.USD","LU0820561909.HKD","LU0466842654.USD","TRUH","XLV","LU2237443465.HKD","LU2361044865.SGD","LU0320765992.SGD","LU1035775433.USD","LU0672654240.SGD","LU2213496289.HKD","IE00B7KXQ091.USD","LU0456855351.SGD","LU2236285917.USD","SG9999001176.USD","IE00BJT1NW94.SGD","LU0097036916.USD","LU2462157665.USD","LU0133085943.USD","LU0385154629.USD","TMED","LU0158827948.USD","BK4581","IE00BJJMRY28.SGD","LLYX","RXL","LU2168564495.EUR","BK4007","BK4585","LU0943347566.SGD","LU2324357040.USD","LU2168563687.JPY","LU2087625088.SGD","LU1061106388.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665390614","title":"Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665390614","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665390614?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768672,"startTime":"0","endTime":"0","summary":"UPDATE 2-Novartis cholesterol setback tests hopes for emerging heart disease drugsLONDON, Sept 7 (Reuters)-Shares of NovartisNOVN.Sfell more than 3% on Monday after its cholesterol drug failed in a cl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL1N44Z05O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELIL","LU2089284900.SGD","MEDI","MHIP","BBH","IYH","PJP","BIB","LU1571399168.USD","LLY","VHT","JDOC","TRUH","FHLC","IE00BJJMRY28.SGD","LLYX","SGXZ99366536.SGD","WDNA","IBB","LU1691799644.USD","RXL","PBE","SLN","XLV","LU2361044865.SGD","OZEM","PPH","ELIS","LU1267930730.SGD","MEDX","LU0823434583.USD","LU0097036916.USD","FTXH","IXJ","NAMS","LLYZ","AMGN","LU2750360641.GBP","AGNG","GDOC","IBBQ","TBXU","CANC","TMED","HRTS","THNR","LLII","ILDR","IHE","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665354019","title":"Guardant announces FDA approval of Guardant360 CDx as companion diagnostic","url":"https://stock-news.laohu8.com/highlight/detail?id=2665354019","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665354019?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:15","pubTimestamp":1788560112,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced that the U.S. Food and Drug Administration has approved Guardant360 CDx as a companion diagnostic to identify patien...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRTY","HELX","BBP","EKG","GNOM","IYH","LU0889565916.HKD","NVIB","IDNA","PTH","IEIH","GNMX","TECB","FFOX","BK4196","BK4588","MRNY","GH","PSCH","SYNB","LU0320765992.SGD","PINK","IBB","LFSC","MRNX","TBXU","BK4551","GDOC","BMED","XLVX","LU0109394709.USD","BK4535","BK4585","LABU","MEDI","RSPH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}